Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study
Giovannoni, Gavin, Soelberg Sorensen, Per, Cook, Stuart, Rammohan, Kottil, Rieckmann, Peter, Comi, Giancarlo, Dangond, Fernando, Adeniji, Abidemi K, Vermersch, Patrick
Published in Multiple sclerosis (01.10.2018)
Published in Multiple sclerosis (01.10.2018)
Get full text
Journal Article
Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study
Martinez-Lapiscina, Elena H, MD, Arnow, Sam, BS, Wilson, James A, BS, Saidha, Shiv, MD, Preiningerova, Jana Lizrova, MD, Oberwahrenbrock, Timm, MD, Brandt, Alexander U, MD, Pablo, Luis E, MD, Guerrieri, Simone, MD, Gonzalez, Ines, MD, Outteryck, Olivier, MD, Mueller, Ann-Kristin, BS, Albrecht, Phillip, MD, Chan, Wesley, BS, Lukas, Sebastian, BS, Balk, Lisanne J, PhD, Fraser, Clare, MD, Frederiksen, Jette L, Prof, Resto, Jennifer, BS, Frohman, Teresa, MD, Cordano, Christian, MD, Zubizarreta, Irati, MD, Andorra, Magi, BSc, Sanchez-Dalmau, Bernardo, MD, Saiz, Albert, MD, Bermel, Robert, MD, Klistorner, Alexander, PhD, Petzold, Axel, MD, Schippling, Sven, MD, Costello, Fiona, MD, Aktas, Orhan, Prof, Vermersch, Patrick, Prof, Oreja-Guevara, Celia, MD, Comi, Giancarlo, Prof, Leocani, Letizia, MD, Garcia-Martin, Elena, MD, Paul, Friedemann, Prof, Havrdova, Eva, MD, Frohman, Elliot, Prof, Balcer, Laura J, Prof, Green, Ari J, MD, Calabresi, Peter A, Prof, Villoslada, Pablo, Prof
Published in Lancet neurology (01.05.2016)
Published in Lancet neurology (01.05.2016)
Get full text
Journal Article
Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial
Leist, Thomas P, Prof, Comi, Giancarlo, Prof, Cree, Bruce A C, Prof, Coyle, Patricia K, Prof, Freedman, Mark S, Prof, Hartung, Hans-Peter, Prof, Vermersch, Patrick, Prof, Casset-Semanaz, Florence, MS, Scaramozza, Matthew, MA
Published in Lancet neurology (01.03.2014)
Published in Lancet neurology (01.03.2014)
Get full text
Journal Article
Radiologically isolated syndrome: 5-year risk for an initial clinical event
Okuda, Darin T, Siva, Aksel, Kantarci, Orhun, Inglese, Matilde, Katz, Ilana, Tutuncu, Melih, Keegan, B Mark, Donlon, Stacy, Hua, Le H, Vidal-Jordana, Angela, Montalban, Xavier, Rovira, Alex, Tintoré, Mar, Amato, Maria Pia, Brochet, Bruno, de Seze, Jérôme, Brassat, David, Vermersch, Patrick, De Stefano, Nicola, Sormani, Maria Pia, Pelletier, Daniel, Lebrun, Christine
Published in PloS one (05.03.2014)
Published in PloS one (05.03.2014)
Get full text
Journal Article
Torben Fog - A Danish pioneer in a multi-faceted spectrum of multiple sclerosis research
Sørensen, Per Soelberg, Bramow, Stephan, Magyari, Melinda, Werdelin, Lene, Koch-Henriksen, Nils, Vermersch, Patrick, Sellebjerg, Finn
Published in Multiple sclerosis (01.05.2024)
Published in Multiple sclerosis (01.05.2024)
Get more information
Journal Article
Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study
Giovannoni, Gavin, Soelberg Sorensen, Per, Cook, Stuart, Rammohan, Kottil W, Rieckmann, Peter, Comi, Giancarlo, Dangond, Fernando, Hicking, Christine, Vermersch, Patrick
Published in Multiple sclerosis (01.05.2019)
Published in Multiple sclerosis (01.05.2019)
Get full text
Journal Article
Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis
Giovannoni, Gavin, Prof, Cook, Stuart, Prof, Rammohan, Kottil, Prof, Rieckmann, Peter, MD, Sørensen, Per Soelberg, Prof, Vermersch, Patrick, Prof, Hamlett, Anthony, PhD, Viglietta, Vissia, MD, Greenberg, Steven, MD
Published in Lancet neurology (01.04.2011)
Published in Lancet neurology (01.04.2011)
Get full text
Journal Article
Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years
Cree, Bruce AC, Arnold, Douglas L, Fox, Robert J, Gold, Ralf, Vermersch, Patrick, Benedict, Ralph HB, Bar-Or, Amit, Piani-Meier, Daniela, Rouyrre, Nicolas, Ritter, Shannon, Kilaru, Ajay, Karlsson, Goeril, Giovannoni, Gavin, Kappos, Ludwig
Published in Multiple sclerosis (01.09.2022)
Published in Multiple sclerosis (01.09.2022)
Get full text
Journal Article
Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study
Comi, Giancarlo, Cook, Stuart, Rammohan, Kottil, Soelberg Sorensen, Per, Vermersch, Patrick, Adeniji, Abidemi K., Dangond, Fernando, Giovannoni, Gavin
Published in Therapeutic advances in neurological disorders (01.01.2018)
Published in Therapeutic advances in neurological disorders (01.01.2018)
Get full text
Journal Article
Effect of siponimod on magnetic resonance imaging measures of neurodegeneration and myelination in secondary progressive multiple sclerosis: Gray matter atrophy and magnetization transfer ratio analyses from the EXPAND phase 3 trial
Arnold, Douglas L, Piani-Meier, Daniela, Bar-Or, Amit, Benedict, Ralph HB, Cree, Bruce AC, Giovannoni, Gavin, Gold, Ralf, Vermersch, Patrick, Arnould, Sophie, Dahlke, Frank, Hach, Thomas, Ritter, Shannon, Karlsson, Göril, Kappos, Ludwig, Fox, Robert J
Published in Multiple sclerosis (01.09.2022)
Published in Multiple sclerosis (01.09.2022)
Get full text
Journal Article
Expert opinion on the use of cladribine tablets in clinical practice
Sørensen, Per Soelberg, Centonze, Diego, Giovannoni, Gavin, Montalban, Xavier, Selchen, Daniel, Vermersch, Patrick, Wiendl, Heinz, Yamout, Bassem, Salloukh, Hashem, Rieckmann, Peter
Published in Therapeutic Advances in Neurological Disorders (2020)
Published in Therapeutic Advances in Neurological Disorders (2020)
Get full text
Book Review
Journal Article
Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial
Dubois, Bruno, López-Arrieta, Jesús, Lipschitz, Stanley, Doskas, Triantafyllos, Spiru, Luiza, Moroz, Svitlana, Venger, Olena, Vermersch, Patrick, Moussy, Alain, Mansfield, Colin D, Hermine, Olivier, Tsolaki, Magda
Published in Alzheimer's research & therapy (28.02.2023)
Published in Alzheimer's research & therapy (28.02.2023)
Get full text
Journal Article
CONCERTO: A randomized, placebo-controlled trial of oral laquinimod in relapsing-remitting multiple sclerosis
Comi, Giancarlo, Dadon, Yuval, Sasson, Nissim, Steinerman, Joshua R, Knappertz, Volker, Vollmer, Timothy L, Boyko, Alexey, Vermersch, Patrick, Ziemssen, Tjalf, Montalban, Xavier, Lublin, Fred D, Rocca, Maria A, Volkinshtein, Rita, Rubinchick, Svetlana, Halevy, Nitsan, Filippi, Massimo
Published in Multiple sclerosis (01.04.2022)
Published in Multiple sclerosis (01.04.2022)
Get more information
Journal Article
Siponimod: Disentangling disability and relapses in secondary progressive multiple sclerosis
Cree, Bruce AC, Magnusson, Baldur, Rouyrre, Nicolas, Fox, Robert J, Giovannoni, Gavin, Vermersch, Patrick, Bar-Or, Amit, Gold, Ralf, Piani Meier, Daniela, Karlsson, Göril, Tomic, Davorka, Wolf, Christian, Dahlke, Frank, Kappos, Ludwig
Published in Multiple sclerosis (01.09.2021)
Published in Multiple sclerosis (01.09.2021)
Get full text
Journal Article
Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice
Rieckmann, Peter, Centonze, Diego, Giovannoni, Gavin, Hua, Le H., Oreja-Guevara, Celia, Selchen, Daniel, Sørensen, Per Soelberg, Vermersch, Patrick, Wiendl, Heinz, Salloukh, Hashem, Yamout, Bassem
Published in Therapeutic Advances in Neurological Disorders (01.12.2021)
Published in Therapeutic Advances in Neurological Disorders (01.12.2021)
Get full text
Book Review
Journal Article
Using personalized prognosis in the treatment of relapsing multiple sclerosis: A practical guide
Van Wijmeersch, Bart, Hartung, Hans-Peter, Vermersch, Patrick, Pugliatti, Maura, Pozzilli, Carlo, Grigoriadis, Nikolaos, Alkhawajah, Mona, Airas, Laura, Linker, Ralf, Oreja-Guevara, Celia
Published in Frontiers in immunology (27.09.2022)
Published in Frontiers in immunology (27.09.2022)
Get full text
Journal Article
L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients
Schwab, Nicholas, Schneider-Hohendorf, Tilman, Posevitz, Vilmos, Breuer, Johanna, Göbel, Kerstin, Windhagen, Susanne, Brochet, Bruno, Vermersch, Patrick, Lebrun-Frenay, Christine, Posevitz-Fejfár, Anita, Capra, Ruggero, Imberti, Luisa, Straeten, Vera, Haas, Juergen, Wildemann, Brigitte, Havla, Joachim, Kümpfel, Tania, Meinl, Ingrid, Niessen, Kyle, Goelz, Susan, Kleinschnitz, Christoph, Warnke, Clemens, Buck, Dorothea, Gold, Ralf, Kieseier, Bernd C, Meuth, Sven G, Foley, John, Chan, Andrew, Brassat, David, Wiendl, Heinz
Published in Neurology (03.09.2013)
Published in Neurology (03.09.2013)
Get more information
Journal Article
Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data
Coles, Alasdair J, Jones, Joanne L, Vermersch, Patrick, Traboulsee, Anthony, Bass, Ann D, Boster, Aaron, Chan, Andrew, Comi, Giancarlo, Fernández, Óscar, Giovannoni, Gavin, Kubala Havrdova, Eva, LaGanke, Christopher, Montalban, Xavier, Oreja-Guevara, Celia, Piehl, Fredrik, Wiendl, Heinz, Ziemssen, Tjalf
Published in Multiple sclerosis (01.04.2022)
Published in Multiple sclerosis (01.04.2022)
Get full text
Journal Article